DRTS
Price
$3.91
Change
+$0.01 (+0.26%)
Updated
Jan 17 closing price
Capitalization
274.1M
46 days until earnings call
SNPX
Price
$3.30
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
4.47M
Ad is loading...

DRTS vs SNPX

Header iconDRTS vs SNPX Comparison
Open Charts DRTS vs SNPXBanner chart's image
Alpha Tau Medical
Price$3.91
Change+$0.01 (+0.26%)
Volume$92.32K
Capitalization274.1M
Synaptogenix
Price$3.30
Change-$0.00 (-0.00%)
Volume$10.45K
Capitalization4.47M
DRTS vs SNPX Comparison Chart
Loading...
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRTS vs. SNPX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTS is a Hold and SNPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (DRTS: $3.91 vs. SNPX: $3.30)
Brand notoriety: DRTS and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRTS: 120% vs. SNPX: 44%
Market capitalization -- DRTS: $274.1M vs. SNPX: $4.47M
DRTS [@Biotechnology] is valued at $274.1M. SNPX’s [@Biotechnology] market capitalization is $4.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRTS’s FA Score shows that 0 FA rating(s) are green whileSNPX’s FA Score has 2 green FA rating(s).

  • DRTS’s FA Score: 0 green, 5 red.
  • SNPX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNPX is a better buy in the long-term than DRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRTS’s TA Score shows that 4 TA indicator(s) are bullish while SNPX’s TA Score has 6 bullish TA indicator(s).

  • DRTS’s TA Score: 4 bullish, 4 bearish.
  • SNPX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNPX is a better buy in the short-term than DRTS.

Price Growth

DRTS (@Biotechnology) experienced а +21.05% price change this week, while SNPX (@Biotechnology) price change was +5.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

DRTS is expected to report earnings on May 21, 2025.

SNPX is expected to report earnings on May 29, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRTS($274M) has a higher market cap than SNPX($4.47M). DRTS YTD gains are higher at: 26.129 vs. SNPX (-4.899). SNPX has higher annual earnings (EBITDA): -6.76M vs. DRTS (-29.1M). DRTS has more cash in the bank: 65.2M vs. SNPX (22.1M). DRTS (0) and SNPX (0) have equivalent revenues.
DRTSSNPXDRTS / SNPX
Capitalization274M4.47M6,124%
EBITDA-29.1M-6.76M430%
Gain YTD26.129-4.899-533%
P/E RatioN/A3.75-
Revenue00-
Total Cash65.2M22.1M295%
Total Debt12.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
DRTSSNPX
RSI
ODDS (%)
Bearish Trend 12 days ago
72%
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
61%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
52%
Bullish Trend 12 days ago
79%
MACD
ODDS (%)
Bullish Trend 12 days ago
60%
Bullish Trend 12 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
56%
Bullish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
54%
Bullish Trend 12 days ago
77%
Advances
ODDS (%)
Bullish Trend 12 days ago
62%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 28 days ago
73%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
75%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
44%
Bullish Trend 12 days ago
85%
View a ticker or compare two or three
Ad is loading...
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSMVX397.732.01
+0.51%
Vanguard S&P Small-Cap 600 Val Idx Instl
MKECX10.790.04
+0.37%
BlackRock Emerging Markets Ex-China K
TMCJX49.900.14
+0.28%
Touchstone Mid Cap C
KGIIX12.970.03
+0.23%
Kopernik International I
GIDAX7.000.01
+0.14%
Goldman Sachs Intl Eq Div & Prem A

DRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRTS has been loosely correlated with FRTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if DRTS jumps, then FRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
+0.26%
FRTX - DRTS
37%
Loosely correlated
N/A
ARDX - DRTS
29%
Poorly correlated
-2.91%
SAGE - DRTS
26%
Poorly correlated
+1.58%
SNPX - DRTS
24%
Poorly correlated
N/A
HOOK - DRTS
24%
Poorly correlated
+0.52%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
N/A
NCNA - SNPX
92%
Closely correlated
+2.70%
RNAC - SNPX
91%
Closely correlated
+1.90%
AGEN - SNPX
91%
Closely correlated
+10.48%
ALLR - SNPX
87%
Closely correlated
+1.94%
NRXP - SNPX
84%
Closely correlated
-5.87%
More